Estimating prevalence of early symptomatic Alzheimer's disease in the United States

INTRODUCTION: Understanding the prevalence of treatment‐eligible Alzheimer's disease (AD) is crucial for policy planning. METHODS: We used a comprehensive literature review and population cascade approach to estimate the number of amyloid‐positive, clinically diagnosed patients with mild cognit...

Descripción completa

Detalles Bibliográficos
Autores principales: Spargo, Drew, Zur, Richard, Lin, Pei‐Jung, Synnott, Patricia, Klein, Eric, Hartry, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682565/
https://www.ncbi.nlm.nih.gov/pubmed/38034853
http://dx.doi.org/10.1002/dad2.12497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682565/
https://www.ncbi.nlm.nih.gov/pubmed/38034853
http://dx.doi.org/10.1002/dad2.12497

Ejemplares similares